Influenza vaccine effectiveness against hospitalisation with influenza in adults in Australia in 2014

Vaccine

Volumn 33, Issue 51, 2015, Pages 7352-7356

  Cheng, Allen C ^a,b   Kotsimbos, Tom ^a   Kelly, Paul M ^c   Wark, Peter ^d   Hunter, Cameron ^e   Hewagama, Saliya ^f   Friedman, N Deborah ^g   Korman, Tony M ^a   Simpson, Graham ^h   Upham, John W ⁱ   Bowler, Simon ^j   Senenayake, San jaya ^k   Holmes, Mark ^l   Irving, Louis ^m   Brown, Simon G A ⁿ   Waterer, Grant ⁿ   Dwyer, Dominic E ^o   Macartney, Kristine ^p   Blyth, Christopher ⁿ  

^a MONASH UNIVERSITY   (Australia)

^b ALFRED HEALTH   (Australia)

^c ACT Government Health Directorate   (Australia)

^d UNIVERSITY OF NEWCASTLE   (Australia)

^e ROYAL HOBART HOSPITAL   (Australia)

^f AliceSprings Hospital   (Australia)

^g BARWON HEALTH   (Australia)

^h CAIRNS BASE HOSPITAL   (Australia)

ⁱ UNIVERSITY OF QUEENSLAND   (Australia)

^j Mater Hospital   (Australia)

^k AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^l UNIVERSITY OF ADELAIDE   (Australia)

^m UNIVERSITY OF MELBOURNE   (Australia)

ⁿ UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^o UNIVERSITY OF SYDNEY   (Australia)

^p University of Syd ney   (Australia)

more..

Author keywords

Hospitalisation; Influenza vaccination; Test negative design; Vaccine effectiveness

Indexed keywords

INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; AGED; ARTICLE; AUSTRALIA; COMORBIDITY; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FUNCTIONAL STATUS; HOSPITALIZATION; HUMAN; INFLUENZA; INFLUENZA A; INFLUENZA A (H3N2); INFLUENZA B; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; SEASONAL INFLUENZA; SENTINEL SURVEILLANCE; STUDY DESIGN; IMMUNOLOGY; INFLUENZA A VIRUS (H1N1); INFLUENZA, HUMAN; PATHOLOGY; PREGNANCY; RISK ASSESSMENT; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; FEMALE; HOSPITALIZATION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PREGNANCY; RISK ASSESSMENT; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84955279626     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.10.016     Document Type: Article

References (27)

1. ATAGI Australian immunisation handbook 2013, Commonwealth of Australia, Canberra.
2. Osterholm M.T., Kelley N.S., Sommer A., Belongia E.A. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012, 12(1):36-44. (Epub 2011/10/29).
3. Sullivan S.G., Feng S., Cowling B.J. Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review. Expert Rev Vaccines 2014, 13(12):1571-1591. (Epub 2014/10/29).
4. Kelly P.M., Kotsimbos T., Reynolds A., Wood-Baker R., Hancox B., Brown S.G.A., et al. FluCAN 2009: initial results from sentinel surveillance for adult influenza and pneumonia in eight Australian hospitals. Med J Aust 2011, 194(4):169-174.
5. Oken M.M., Creech R.H., Tormey D.C., Horton J., Davis T.E., McFadden E.T., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982, 5(6):649-655.
6. WHO Recommended composition of influenza virus vaccines for use in the 2014 southern hemisphere influenza season 2013, World Health Organisation, Available from 〈http://www.who.int/influenza/vaccines/virus/recommendations/2014_south/en/〉 (cited 2015 July 9).
7. Dept. of Health Australian influenza surveillance report No 08-27 September to 10 October 2014 2014, Australian Department of Health, Canberra.
8. WHO Recommended composition of influenza virus vaccines for use in the 2015 southern hemisphere influenza season 2014, World Health Organisation, Geneva, Available from 〈http://www.who.int/influenza/vaccines/virus/recommendations/201409_recommendation.pdf〉 (cited 2015 July 10).
9. Rodrigues L., Kirkwood B.R. Case-control designs in the study of common diseases: updates on the demise of the rare disease assumption and the choice of sampling scheme for controls. Int J Epidemiol 1990, 19(1):205-213. (Epub 1990/03/01).
10. Smith P.G., Rodrigues L.C., Fine P.E. Assessment of the protective efficacy of vaccines against common diseases using case-control and cohort studies. Int J Epidemiol 1984, 13(1):87-93. (Epub 1984/03/01).
11. Greenland S., Thomas D.C. On the need for the rare disease assumption in case-control studies. Am J Epidemiol 1982, 116(3):547-553. (Epub 1982/09/01).
12. Cheng A.C., Holmes M., Irving L.B., Brown S.G., Waterer G.W., Korman T.M., et al. Influenza vaccine effectiveness against hospitalisation with confirmed influenza in the 2010-11 seasons: a test-negative observational study. PLoS ONE 2013, 8(7):e68760. (Epub 2013/07/23).
13. Cheng A.C., Kotsimbos A.T., Kelly H., Irving L., Bowler S.B., Holmes S., et al. Effectiveness of H1N1/09 monovalent and trivalent influenza vaccines against hospitalization with laboratory-confirmed H1N1/09 influenza in Australia: a test-negative case control study. Vaccine 2011, 29(43):7320-7325.
14. Schafer J.L. Analysis of incomplete multivariate data 1997, Chapman & Hall/CRC, Boca Raton, FL.
15. Cheng A.C., Dwyer D.E., Holmes M., Irving L.B., Brown S.G.A., Waterer G.W., et al. Influenza epidemiology, vaccine coverage and vaccine effectiveness in sentinel Australian hospitals in 2013: the Influenza Complications Alert Network. Commun Dis Intell 2014, 38(2):e143-e149.
16. Ridenhour B.J., Campitelli M.A., Kwong J.C., Rosella L.C., Armstrong B.G., Mangtani P., et al. Effectiveness of inactivated influenza vaccines in preventing influenza-associated deaths and hospitalizations among Ontario residents aged ≥65 years: estimates with generalized linear models accounting for healthy vaccinee effects. PLoS ONE 2013, 8(10):e76318.
17. Turner N., Pierse N., Bissielo A., Huang Q.S., Baker M.G., Widdowson M.A., et al. The effectiveness of seasonal trivalent inactivated influenza vaccine in preventing laboratory confirmed influenza hospitalisations in Auckland, New Zealand in 2012. Vaccine 2014, 32(29):3687-3693.
18. Cowling B.J., Chan K.H., Feng S., Chan E.L., Lo J.Y., Peiris J.S., et al. The effectiveness of influenza vaccination in preventing hospitalizations in children in Hong Kong, 2009-2013. Vaccine 2014, 32(41):5278-5284.
19. McNeil S., Shinde V., Andrew M., Hatchette T., Leblanc J., Ambrose A., et al. Interim estimates of 2013/14 influenza clinical severity and vaccine effectiveness in the prevention of laboratory-confirmed influenza-related hospitalisation, Canada, February 2014. Eur Surveill 2014, 19(9). pii: 20729. 10.2807/1560-7917.ES2014.19.9.20729.
20. Rondy M., Launay O., Puig-Barberà J., Gefenaite G., Castilla J., de Gaetano Donati K., et al. 2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals. Eur Surveill 2015, 20(2). pii: 21011. 10.2807/1560-7917.ES2015.20.2.21011.
21. Flannery B., Clippard J., Zimmerman R.K., Nowalk M.P., Jackson M.L., Jackson L.A., et al. Early estimates of seasonal influenza vaccine effectiveness-United States, January 2015. MMWR Morb Mortal Wkly Rep 2015, 64(1):10-15. (Epub 2015/01/16).
22. Skowronski D., Chambers C., Sabaiduc S., De Serres G., Dickinson J., Winter A., et al. Interim estimates of 2014/15 vaccine effectiveness against influenza A(H3N2) from Canada s Sentinel Physician Surveillance Network, January 2015. Eur Surveill 2015, 20(4). pii: 21022. 10.2807/1560-7917.ES2015.20.4.21022.
23. Goodwin K., Viboud C., Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006, 24(8):1159-1169. (Epub 2005/10/11).
24. Simonsen L., Taylor R.J., Viboud C., Miller M.A., Jackson L.A. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 2007, 7(10):658-666. (Epub 2007/09/28).
25. Hutchison B.G. Measurement of influenza vaccination status of the elderly by mailed questionnaire: response rate, validity and cost. Can J Public Health Revue canadienne de sante publique 1989, 80(4):271-275. (Epub 1989/07/01).
26. Mangtani P., Shah A., Roberts J.A. Validation of influenza and pneumococcal vaccine status in adults based on self-report. Epidemiol Infect 2007, 135(1):139-143. (Epub 2006/06/03).
27. Skull S.A., Andrews R.M., Byrnes G.B., Kelly H.A., Nolan T.M., Brown G.V., et al. Validity of self-reported influenza and pneumococcal vaccination status among a cohort of hospitalized elderly inpatients. Vaccine 2007, 25(25):4775-4783. (Epub 2007/05/15).